Labs / CDMO: development & manufacturing

Amphix Bio
Chicago, IL, United States · amphixbio.com
GMP
Amphix Bio develops peptide therapeutics based on supramolecular chemistry for degenerative diseases and traumatic injury. Its work is centered on the Supramolecular Therapeutic Peptide (STP) platform, which aims to modulate cell and tissue biology and activate regenerative pathways.
They take quote requests by email.
What they offer
Supramolecular Therapeutic Peptide (STP) platform development
Develops a peptide therapeutic platform using supramolecular chemistry to create dynamic 3D scaffolds that activate regenerative signaling.
Peptide therapeutic development
Develops peptide therapeutics intended to treat degenerative diseases and promote healing after traumatic injury.
What they work on
- Modalities
- Peptide, Cell therapy
- Therapeutic areas
- degenerative diseases, traumatic injury, stroke, spinal cord injury, cartilage repair
- Quality
- FDA Orphan Drug Designation (acute spinal cord injury therapeutic)
- Address
- 400 North Aberdeen Street Suite 900 Chicago, IL 60642
Similar labs. 3C Therapeutics, Artis, Aurigene Pharmaceutical Services, Crystal NAX
Found in a contract services directory. Listing built from amphixbio.com. Work here? Claim this listing.